Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Stomach Ulcer D013276 75 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Otitis Media D010033 12 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Bacterial Infections D001424 21 associated lipids
Pain D010146 64 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Longo G et al. Azithromycin-induced intrahepatic cholestasis. 1997 Am. J. Med. pmid:9217574
Cameron DJ Effectiveness of early Lyme disease treatment. 1993 Am. J. Med. pmid:8388627
Massarotti EM et al. Treatment of early Lyme disease. 1992 Am. J. Med. pmid:1313637
Cascaval RI and Lancaster DJ Hypersensitivity syndrome associated with azithromycin. 2001 Am. J. Med. pmid:11247598
Neu HC Clinical microbiology of azithromycin. 1991 Am. J. Med. pmid:1656736
Stamm WE Azithromycin in the treatment of uncomplicated genital chlamydial infections. 1991 Am. J. Med. pmid:1656737
Hooton TM A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis. 1991 Am. J. Med. pmid:1656738
Casiano RR Azithromycin and amoxicillin in the treatment of acute maxillary sinusitis. 1991 Am. J. Med. pmid:1656739
Winton JC and Twilla JD Sudden cardiac arrest in a patient on chronic methadone after the addition of azithromycin. 2013 Am. J. Med. Sci. pmid:23103438
Devasia RA et al. Compliance with azithromycin versus erythromycin in the setting of a pertussis outbreak. 2009 Am. J. Med. Sci. pmid:19301451
Sutton AL et al. Perinatal pharmacokinetics of azithromycin for cesarean prophylaxis. 2015 Am. J. Obstet. Gynecol. pmid:25595580
Andrews WW et al. Interconceptional antibiotics to prevent spontaneous preterm birth: a randomized clinical trial. 2006 Am. J. Obstet. Gynecol. pmid:16522388
Jacobson GF et al. A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy. 2001 Am. J. Obstet. Gynecol. pmid:11408852
Tita AT et al. Impact of interconception antibiotics on the endometrial microbial flora. 2007 Am. J. Obstet. Gynecol. pmid:17346530
Grigsby PL et al. Maternal azithromycin therapy for Ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate model. 2012 Am. J. Obstet. Gynecol. pmid:23111115
Ward E and Duff P A comparison of 3 antibiotic regimens for prevention of postcesarean endometritis: an historical cohort study. 2016 Am. J. Obstet. Gynecol. pmid:26901276
Gray RH et al. Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. 2001 Am. J. Obstet. Gynecol. pmid:11717659
Ramsey PS et al. Maternal and transplacental pharmacokinetics of azithromycin. 2003 Am. J. Obstet. Gynecol. pmid:12634646
Lin KJ et al. Safety of macrolides during pregnancy. 2013 Am. J. Obstet. Gynecol. pmid:23254249
Tita AT et al. Impact of extended-spectrum antibiotic prophylaxis on incidence of postcesarean surgical wound infection. 2008 Am. J. Obstet. Gynecol. pmid:18771992
Johnson RB The role of azalide antibiotics in the treatment of Chlamydia. 1991 Am. J. Obstet. Gynecol. pmid:1645503
Kelsey JJ et al. Presence of azithromycin breast milk concentrations: a case report. 1994 Am. J. Obstet. Gynecol. pmid:8178871
Keelan JA et al. Maternal-amniotic-fetal distribution of macrolide antibiotics following intravenous, intramuscular, and intraamniotic administration in late pregnant sheep. 2011 Am. J. Obstet. Gynecol. pmid:21481833
Tita AT et al. Clinical trial of interconceptional antibiotics to prevent preterm birth: subgroup analyses and possible adverse antibiotic-microbial interaction. 2007 Am. J. Obstet. Gynecol. pmid:17904962
Uy HS et al. Infectious crystalline keratopathy and endophthalmitis secondary to Mycobacterium abscessus in a monocular patient with Stevens-Johnson syndrome. 1999 Am. J. Ophthalmol. pmid:10030567
Kuehne JJ et al. Corneal pharmacokinetics of topically applied azithromycin and clarithromycin. 2004 Am. J. Ophthalmol. pmid:15488779
Bosch-Driessen LH et al. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. 2002 Am. J. Ophthalmol. pmid:12095805
Stewart WC et al. Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens. 2010 Am. J. Ophthalmol. pmid:20813346
Wolle MA et al. Impact of Trichiasis surgery on physical functioning in Ethiopian patients: STAR trial. 2011 Am. J. Ophthalmol. pmid:21333268
Katusic D et al. Azithromycin vs doxycycline in the treatment of inclusion conjunctivitis. 2003 Am. J. Ophthalmol. pmid:12654359
Abelson MB et al. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial. 2008 Am. J. Ophthalmol. pmid:18374301
Ness PJ et al. An anterior chamber toxicity study evaluating Besivance, AzaSite, and Ciprofloxacin. 2010 Am. J. Ophthalmol. pmid:20678751
Fan LC et al. Macrolides protect against infection via inhibition of inflammasomes. 2017 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:28684545
Shinkai M et al. Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells. 2006 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:16085674
Blau H et al. Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line. 2007 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:17012372
Tarran R et al. Nonantibiotic macrolides prevent human neutrophil elastase-induced mucus stasis and airway surface liquid volume depletion. 2013 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:23542952
Kadova Z et al. IL-1 receptor blockade alleviates endotoxin-mediated impairment of renal drug excretory functions in rats. 2015 Am. J. Physiol. Renal Physiol. pmid:25503728
Meyer M et al. Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis. 2009 Am. J. Respir. Cell Mol. Biol. pmid:19244203
Halldorsson S et al. Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection. 2010 Am. J. Respir. Cell Mol. Biol. pmid:19372247
Bergamini G et al. Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells. 2009 Am. J. Respir. Cell Mol. Biol. pmid:19097986
Kanazawa S et al. Azithromycin and bronchiolitis obliterans. 2004 Am. J. Respir. Crit. Care Med. pmid:14982826
Tsai WC et al. Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection. 2004 Am. J. Respir. Crit. Care Med. pmid:15361366
Jeong BH et al. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. 2015 Am. J. Respir. Crit. Care Med. pmid:25393520
Restrepo MI and Anzueto A Reply: Azithromycin: We're there! 2014 Am. J. Respir. Crit. Care Med. pmid:25360733
Albert RK et al. Azithromycin: We're there! 2014 Am. J. Respir. Crit. Care Med. pmid:25360732
Barker PM et al. Effect of macrolides on in vivo ion transport across cystic fibrosis nasal epithelium. 2005 Am. J. Respir. Crit. Care Med. pmid:15657462
Choi GE et al. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. 2012 Am. J. Respir. Crit. Care Med. pmid:22878281
Binder AM et al. Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. 2013 Am. J. Respir. Crit. Care Med. pmid:23927602
O'Beirne SL et al. Severe Cavitary, Fistulating Mycobacterium avium-intracellulare Complex Disease in an Immunocompetent Host. 2015 Am. J. Respir. Crit. Care Med. pmid:26244303
Angel LF et al. Azithromycin in bronchiolitis obliterans: is the evidence strong enough? 2006 Am. J. Respir. Crit. Care Med. pmid:16467178